As AMPK is activated by several existing drugs used to treat type 2 diabetes, including metformin and thiazolidinediones (Bijland et al., 2013), there is a need to understand the actions of AMPK activation in metabolic tissues. Here, PRKAA1 is linked to type 2 diabetes mellitus.